— Know what they know.
Not Investment Advice

SIEN NASDAQ

Sientra, Inc.
1W: -8.9% 1M: -79.0% 3M: -88.8% 1Y: -94.8% 3Y: -99.9% 5Y: -99.9%
$0.17
Last traded 2024-03-18 — delisted
NASDAQ · Healthcare · Medical - Devices · $2.1M mcap · 11M float · 22.51% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.1M
52W Range0.1566-4.937
Volume3,327,525
Avg Volume2,486,690
Beta2.03
Dividend—
Analyst Ratings
11 Buy 2 Hold 0 Sell
Consensus Buy
Company Info
CEORonald Menezes
Employees304
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-10-29
420 South Fairview Avenue
Santa Barbara, CA 93117
US
805 562 3500
About Sientra, Inc.

Sientra, Inc. is a global medical aesthetics firm specializing in the development and distribution of a diverse range of aesthetic medical solutions. Its core offerings encompass silicone gel implants, utilized for both breast enhancement and reconstructive surgeries, alongside breast tissue expanders and various scar management solutions. These products are marketed under prominent brands such as Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. Beyond breast-related items, the company's portfolio extends to include products for body sculpting, facial and nasal implants, and saline-filled sizers. Sientra caters to a broad clientele, including hospitals, surgical facilities, plastic surgeons, dermatologists, and other specialized medical practitioners across the United States and internationally. Established in 2003, the enterprise was initially known as Juliet Medical, Inc., before adopting the Sientra, Inc. designation in April 2007. Its corporate headquarters are situated in Santa Barbara, California.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Menezes Ronald F-InKind 3,625 $0.71 2023-11-13
Van Hove Caroline F. F-InKind 741 $0.71 2023-11-13
Bennett Oliver Chris A-Award 2,739 $1.75 2023-09-07
Schmidt Andrew C F-InKind 561 $3.86 2023-08-03
SCHAISON PHILIPPE A-Award 12,000 — 2023-06-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms